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Introduction 
Urolithiasis and its management has become a global growing concern posing both clinical 
and economic burden for healthcare systems (1). With the steady rise of populations, the 
annual prevalence of urinary tract stones is increasing and as well as the requirement for 
hospital visits (2).   
Ureter stone has a lifetime prevalence of 10% to 15% and is one of the most common 
urological presentations in the emergency department (3, 4). Patients experience severe 
flank pain radiating to groin because of sudden obstruction of the ureter, with associated 
risks of hydronephrosis, renal damage, infection of the urinary tract and severe sepsis (5).
 Ureteric stones can be managed by different modalities; expectant management 
with spontaneous passage of the stone, with or without medical expulsive therapy as an 
adjuvant (6). Those that fail to pass stones spontaneously will require more invasive 
options.  
In the absence of infection, severe obstruction, renal impairment and uncontrollable pain 
expectant management of spontaneous stone passage is preferred, as long as the passage 
is likely in a reasonable time frame (7, 8).  There is no clear consensus of recommendations 
for expectant management of ureteric stones either by the American urological association 
(AUA) or by the European association of urology (EAU), mainly due to studies with 
insufficient supporting data. However, current AUA guideline recommends trial of 
spontaneous passage for ≤ 10 mm stone (9) and EAU recommends the same management 
for ‘small’ ureteral stones referring to ≤ 6mm stones, if active removal is not indicated 
(10). 
It is very important to understand the natural history of ureter stone disease especially to 
recognize the cohort of patients and their stone characteristics, who would expel the stone 
spontaneously and also to understand the time frame they can be safely observed with 
least undesirable complications. 
However, current literature lacks high-level evidence on spontaneous passage rates. 
Therefore, we aimed to conduct a systematic review of all randomised trials to better 
establish an evidence based natural history of stone expulsion, which can aid management 
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of ureteral stones. In addition, we will look at all studies that specifically researched the 
natural history of stone expulsion.  
Methodology 
Search strategy 
The systematic review of the literature was performed using Cochrane and PRISMA 
guidelines (11, 12). The search strategy included the following databases: The US National 
Library of Medicine’s life science database (MEDLINE) (1980- August 2017), EMBASE (1980- 
August 2017), Cochrane Central Register of Controlled Trials - CENTRAL (in The Cochrane 
Library - 2017), CINAHL (1980- August 2017), Clinicaltrials.gov, Google Scholar and 
Individual urological journals. 
Search terms used in conjunction with each other included: ‘urolithiasis’, ‘urinary calculi’, 
‘renal calculi’, ‘ureteric calculi’, ‘urinary stones’, and ‘Randomized controlled trial’. 
Medical Subject Headings (MeSH) phrases included:  
- (("Calculi"[Mesh] OR "Urinary Calculi"[Mesh] OR “Kidney Calculi"[Mesh]) AND 
"Randomized Controlled Trial" [Publication Type]) 
- (("Adrenergic Alpha-Antagonists"[Mesh]) AND "Urinary Calculi"[Mesh]) AND 
"Randomized Controlled Trial" [Publication Type])) 
- (("Calcium Channel Blockers"[Mesh]) AND "Urinary Calculi"[Mesh]) AND 
"Randomized Controlled Trial" [Publication Type])) 
Study Selection 
All languages were included if data was extractable, also references of searched papers 
were evaluated for further studies for potential inclusion. Authors were contacted 
wherever the data was not available or not clear, to be able to adequately assess inclusion 
of their study. If data was not extractable, provided or clarified, the study was excluded.  
Four reviewers (SY, TA, and OA) identified studies that appeared to fit the inclusion criteria 
for full review. Four reviewers (SY, TA, BS, and OA) independently selected studies for 
inclusion. Disagreement between the authors in study inclusion was resolved by consensus. 
D
ow
nl
oa
de
d 
by
 G
LA
SG
O
W
 U
N
IV
ER
SI
TY
 L
IB
RA
RY
/S
w
et
s /
 8
81
35
88
8 
fro
m
 o
nl
in
e.l
ie
be
rtp
ub
.co
m
 at
 0
3/
02
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Page 4 of 29 
 
 
 
4 
Jo
ur
na
l o
f E
nd
ou
ro
lo
gy
 
Na
tu
ra
l H
ist
or
y 
of
 C
on
se
rv
at
iv
el
y 
M
an
ag
ed
 U
re
te
ric
 S
to
ne
s f
ro
m
 a
 cu
m
ul
at
iv
e 
an
al
ys
is 
of
 6
60
0 
pa
tie
nt
s (
DO
I: 
10
.1
08
9/
en
d.
20
17
.0
84
8)
 
Th
is 
pa
pe
r h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 co
py
ed
iti
ng
 a
nd
 p
ro
of
 co
rr
ec
tio
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
Data Extraction 
Data of each included study was independently extracted initially by 3 authors (SY, TA, and 
PJ) after which a senior author (OA) extracted the data independently and cross checked 
each data extraction to ensure quality assurance of data across the board. 
All studies comparing a treatment modality to a placebo were included. Published trials on 
adult patients of placebo arms of stone expulsions and all studies looking at the natural 
history of stone expulsions were included. We excluded studies on children or stone 
management studies that did not include a non-treatment arm, ie trials of ESWL, URs, or 
PCNLs in isolation,  with no placebo non-treatment group. We extracted data of the 
placebo arms of trials, where no medical expulsive therapy or surgical treatment has been 
carried out, to be able to determine the natural course of stone expulsion and 
cumulatively analysed these with that of studies reporting the natural history.  
The following variables were extracted from each study: patient and stone demographics, 
expulsion rates, expulsion times, and side effect of the medication. The data of each study 
was grouped into a meta-analysis, in an intention to treat basis.  
Statistical Analysis and Quality Assessment 
The data of the placebo arms of each trial was extracted to represent the natural history of 
stones. We divided each subcategory into overall expulsion rate, stones in the upper, mid, 
or lower ureter, and stones <5mm and >5mm in size. The results were depicted as 
percentages and an intention to treat basis was used.  
We included all studies looking at the natural history of stone expulsion rates as well as 
RCTs as these studies are more controlled and more reliable that no intervention was done 
for the placebo arm and the results are more likely to represent the true natural history of 
stone expulsion. An assessment of the methodological quality of the RCT was conducted in 
line with the Cochrane handbook (12).  
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Results 
Literature search 
The literature search identified 876 studies, of which 697 were excluded due to non-
relevance based on titles and 179 excluded due to non-relevance based on the abstracts 
(Figure 1). Full manuscripts were evaluated in 91 studies, of which 22 studies were 
excluded due to not meeting inclusion criteria. The remaining 70 studies were included 
that reported on the spontaneous passage of ureteral stones without any medical or 
surgical intervention (Figure 1) (8,13-81). 
Characteristics of the included studies: 
The trials span over 3 decades from1994 with the latest in 2017. While the natural history 
papers spanned from 1977-2017. We were unable to obtain full manuscripts prior to this 
date to analyse, therefore excluded. There was a total of 6642 patients conservatively 
treated. The age range was between 17 and 74 years of age. All the natural history studies 
looked at stone expulsion with no intervention. Table 1 depicts the patient and stone 
demographics. 
All the RCTs reported on the spontaneous stone passage rates with no intervention. 
Regarding stone location within the ureter, 15 studies reported on upper tract stones, 10 
on mid ureteric stones, and 65 on distal ureter stones. Nine studies reporting on more than 
one location (24, 38, 40, 42, 44, 47, 55, 65, 69). Sixteen studies reported on stones <5mm 
(29, 33, 34, 39, 40, 44, 46, 48, 55, 69, 75, 76, 77, 79,  80, 81), while 19 reported on stones 
>5mm.(22, 24, 29, 30,33, 35, 39, 40, 44, 48, 55, 57, 60, 69, 75, 76, 77, 79, 81). Twelve of the 
studies reported on stones in the distal ureter and >5mm in size (22, 24, 29, 30, 35, 48, 57, 
60, 75, 76, 77, 81), while other no studies were found that data can be extracted for stones 
combining locality and stone size.  
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Cumulative analysis results 
Stone Passage: 
Overall 64.4% patients successfully passed their stones without any medical or surgical 
interventions (table 2).  
Dividing the stones in locality: 49.1% of upper ureteric stones, 58.1% of mid ureteric 
stones, and 68.1% of distal ureteric stones passed spontaneously (table 2).  
Groups based on size: 75.3% of stones <5mm passed spontaneously irrespective of 
location as opposed to 61.6% of stones >5mm that passed spontaneously (table 2).  
Requiring Rehospitalisation: 
Nearly 5% required rehospitalisation due to worsening of their condition, ie pain not 
controlled by analgesics or developed a sepsis (162/3035). 
Side Effects: 
Only 1% of patients experienced side effects from analgesia provided (31/2745). These 
included nausea and vomiting being the most common, other side effects included: 
headaches, dizziness, rhinitis, fatigue, hypotension, diarrhoea, and heartburn.  
Methodological quality assessment 
All the studies were reported as Randomised controlled studies, ergo considered high 
quality studies. Figure 2 depicts the summary of the quality assessment based on the 
reviewing author’s judgement of risks of bias for each included study. Of the 63 trials only 
12 had no risk of bias to note (17, 30, 32, 33, 37, 54, 55, 62, 65, 66, 67, 81). 
One trial did not have appropriate randomisation (50). We found that the blinding was the 
main differential aspect of the quality assessment between the studies. Only 14 had 
adequate blinding (13, 17, 22, 23, 30, 33, 37, 53, 55, 62, 65, 66, 67, 81). Furthermore, 
concealment was not mentioned in many of the trials with 50 not mentioning how they 
concealed their study giving leaving an unclear decision on concealment, 2 trials made no 
attempts at concealment (49, 71), while 11 trials had adequate concealment (17, 30, 32, 
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33, 37, 54, 45, 62, 65, 66, 81). Three studies had incomplete outcomes reporting bias (47, 
49, 50). Two other studies had other risk of bias (19, 60). 
Regarding the natural history studies, these were of low evidence as they were all cohort 
retrospective or prospective studies, however each study meticulously delineated their 
methodology protocol and did not have any evidence of selection or reporting bias, and no 
missing data.  
Discussion 
Although it is demonstrated in various studies that small ureteric stones pass 
spontaneously (8), the urologist are frequently challenged with the decision of whether to 
observe a stone in expectation of spontaneous passage, or to intervene surgically (82). 
Studies have also demonstrated that spontaneous passage of ureteric stone is size and 
location dependent (66, 71). The more the distal the stone is in the ureter, the greater is 
the probability of spontaneous passage. Additionally, smaller stones are prone to pass 
quickly when compared to larger stones (8). 
We investigated the outcome of ureter stones in 6642 patients treated by expectant 
management. The incidence of spontaneous passage relating both stone size and location 
was determined from these collated studies. The rate of spontaneous passage for stones 
smaller than 5 mm was 75% compared to 62% for those larger than 5 mm, irrespective of 
their position in the ureter at the time of presentation. While stones discovered in the 
distal third of the ureter had a spontaneous passage rate of 68%, compared with the mid 
third of 58%, and the proximal third of 49%. With a low complication rate.  
Stones Expulsion Rates 
Consideration of various factors is essential to determine the optimal treatment for 
patients with ureteric stone. Canadian urological association guidelines divides these 
factors broadly into four categories namely; (i) stone factors consisting of location, size, 
composition, presence and duration of obstruction, (ii) clinical factors consisting of 
symptom severity, patient’s expectations, associated infection, obesity, coagulopathy, 
hypertension and solitary kidney, (iii) anatomic factors like horseshoe kidney, 
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ureteropelvic junction obstruction and renal ectopia and (iv) technical factors of 
availability of equipment, expertise and cost. The guideline also emphasizes the selection 
of any modality of treatment to be based on ‘achieving maximal stone clearance with 
minimal morbidity to the patient (7). 
Various studies have demonstrated spontaneous stone passage rate in relation to the 
stone size; Ueno et al in 1977 showed spontaneous passage rates of 38% and 1.2% in 
stones of <4 mm and >6 mm (71), Hubner et al in 1993 reported a communitive analysis of 
the literature, which showed 57% spontaneous passage of stones <4mm, 4 to 6 mm stones 
passed in 35%, and only 8% in those with stones larger than 6mm (66). Coll et al 
demonstrated close relationship of stone size and spontaneous passage. They reported 
stone size of 1, 4, 7 and 10 mm had spontaneous passage rate of 87%, 72%, 47%, and 27%, 
respectively (65).  
The locations of stones also have been well recognized as an important factor in the 
spontaneous expulsion rate. In 1991, Morse et al demonstrated spontaneous stone 
passage rate of 71% from the distal 46% from the mid and 22% from the proximal ureter 
(68). Hubner et al showed spontaneous passage in 38% of stones located in the distal third 
of the ureter, compared with 15% in the mid third and 18% of stones in the proximal third 
(66). In a retrospective radiologically followed study using unenhanced CT scan, Coll et al, 
2002, reported spontaneous stone passage rate of 75% in distal ureter, 60% for mid 
ureteral stones and 48% for stones in the proximal ureter (65). Sfoungaristos et al, 2012, 
noted spontaneous passage of 50% distal ureter stones, including stones in VUJ and 90% 
passage rate for mid ureter stones (69).  
All these studies highlighted how there are discrepancies in the percentages of stone 
expulsion across the board.  
Timing of stone passage 
Though these natural history of stone studies, gave a rough idea of the rates of 
spontaneous stone passage, evidence from RCTs, has shown heterogenic results. The 
cumulative analysis in this review has yielded a more precise account spontaneous stone 
passages. However, there remains a great disparity in the time to stone passage between 
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all studies, with a wide range from 1 to 4 weeks. Canadian urology guidelines (CUA) and 
European association of urology recommend 90% of chance of spontaneous passage of 
stones less than 5 within 40 days (7,10). This review has found that the majority of stone 
expulsions were within 4 weeks, with an average of about 17 days.  
Nonetheless, this was limited by the fact that all the studies included had limited their 
follow up period to this range, with no longer follow up periods. This was largely based on 
patient safety. Ergo it can be deemed safe practice to consider treatment after of a stone if 
it has not passed after 4 weeks.  
Safety 
The rate of complications has been shown have a direct relation to the duration of 
symptoms. Twenty percent of patients have complications if symptoms are more than 4 
weeks when compared to 7% if symptoms are less than 4 weeks in duration (66). The 
current study revealed that only 5% required readmission and out of which only 1.1% had 
minor side effects in relation to the analgesia used. 
Implications for practice 
Reasonably easy accessibility of equipment (shock wave lithotripsy, semirigid and flexible 
ureteroscopes) increase in number of trained endourologist and patient expectations has 
not only expanded the indications for intervention for ureteric stone but also has spawned 
significant increase in ureteroscopic procedure in last 10years (1, 8). Unfortunately, all 
form of procedures does come with certain risks.   
Observation or expectant management of stone, until stone expels, is one of commonest 
management option for ureteric stone and appears attractive as it avoids invasive 
procedure however is associated with ambiguity and uncertainty, pain, potential loss of 
renal function and most importantly for many, loss of work and family commitments (70). 
The continuously debated topic of assisting stone expulsion with medical therapy adds an 
added question. As shown, α-blockers, specifically tamsulosin, can increase stone 
expulsion rates of stones in the distal ureter and of those of >5mm. Overall can increase 
stone expulsion rates by at least 14% (6, 83, 84, 85).  
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Furthermore, the cost benefit of conservatory managed stones can also sway decision to 
avoid treatment. In the United States, it’s reported that expectant (observation) 
management of ureteric stones has a $1200 cost advantage for distal ureteral stones and a 
$400 for proximal ureteral stones (86). 
We believe that current study is the largest cohort evaluation of natural history of ureteric 
stones and redefines the rate of passage of stones in relation to the size and location 
compared to previous published literature and current international urolithiasis guidelines. 
This also briefly gives an idea on the complication rate involved during the observation for 
the ureteric stones. 
Conclusion 
Expectant management has undeniable role in the treatment of ureteric stone patients. 
The outcome is largely determined on the stone size and location of the stone. Most 
ureteral stones <5mm, especially those located in the mid and distal ureter, will pass 
spontaneously. Hence it is acceptable for the urologist to observe for spontaneous stone 
passage for a period of time. Appropriate follow up of these patients is obligatory to avoid 
complications. If spontaneous passage does not occur within 4 weeks period, intervention 
is recommended. More importantly, this information helps to reduce patients’ anxiety and 
supports them to make an evidence based informed decision about conservative 
management as opposed to invasive treatment. 
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Table 1: Demographics of Included studies 
Author, yr. Age (mean+-SD unless 
specified) 
Gender (M:F) Stone size (mean+-SD unless 
specified) 
Expulsion rate Expulsion time, d 
Abdel-Meguid 
2010 
Med 36 (19-72) 53:22 Median 6 (4-10) 42/75 <6m 17; 7-10m 20
Agrawal 2009 35.3 (22-58) 24:10 6.35 (4-8) 12/34 24.5 
Ahmad 2015  48 5.78 (4–8) 26/48 
Ahmed 2010 38.9±13.3 19:9 5.39±1.81 14/28 13.9±6.99 
Aldemir 2011 43.5 ± 16.6 (18–71) 19:10 6.6 ± 1.7 (4–10) 11/29 7 
Autorino, 2005  43 21:11 5.7 (3–10) 19/32  7.4±2.2 
Alizadeh 2014 19-54 32:14 0.83±4 .81 30/46  4.7±8.03 
Al-Ansari 2010 36.13 ± 9.32  6.04+-2.5 28/46 9.87+-5.4 
Bajwa 2013 33.87+-9.61 19:11 6.63+-1.45 11/30 20.93+-4.43
Balci 2014 34.5±10.2 18:7 6.3 ± 1.5 9/25  10.3 
Borghi, 1994 43 ± 14 25:18 6.8 ± 2.9 24/43  16.4 
Cervenakov, 2002  17–74 33:18  32/51  3.4 
Chau 2011 48.6 ± 11.8  6.9 ± 1.5 17/34 - 
Coll 2002    115/172  
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Cooper, 2000   35 3.86 19/35  11.2 
Dellabella, 2003  38.1 ± 10.6 (18-58) 18:12 5.8 ±1.3 (4-11) 21/30  4.6 
Dellabella, 2005  39.8 ± 12.7 50:20 6.2 ± 1.7 (4-11.8) 45/70 5
De Sio 2006 44.5 ± 11.3 26:20 6.4 ± 1.3 27/46  7.5±1.8 
El-Gamal 2012 36.2 ± 6 34:12 7.7 ± 1.63 12/46  
ElSaid 2015 32.1+-9.2 16:10 5.9+-1.9 7/26 Median 19 (8-25) 
Erturhan, 2007     26/60  
Ferre 2009 45 ± 12  3.8 ± 1 24/37 Median 3 
Furyk 2015 46 (37–55) 127/155 Median 11
Georgescu 2015  45.14+-11.58 26:24 5.1+-2.02 26/50 12.03+-6.22 
Gurbuz 2011 40.3 ± 15.9 22:11 7.13 ± 1.11 3/33 10.55+-6.21 
Han, 2006 42.7 22:10 4.3+-0.61 17/32  8.3+-3.8 
Hermanns 2009 41 (33–54) 36:9 3.8 (3.4-4.3) 40/45 Median 10 
Hubner 1993 47 (10-74) 64:36  30/100  
Ibrahim 2013 36.71 ± 11.64 25:7 5.65+-1.25 14/32
Itoh 2011 56.5 ± 10.1 92 5.67+-2.1 46/92 15.19+-7.14
Itoh 2013 55.8 ± 10.4 56 4.87+-1.98 31/56 13.4+-5.9 
Kaneko 2010 45 ± 8.7 (28–61) 34 4.8±2.1 17/34 17±11 
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Kang 2009 45.19+-12.27 12:9 0.47+-0.08 8/21  
Keshvary, 2006  n/a 24 6.8 11/24  14.2 
Kim 2007 45.7+-13.8 24:18 5.2+-2.6 18/42 18.5+-6.9
Kirac 2013 29.3 ± 7.1 23:16 6.98 ± 2.1 19/39 15.3 ± 5.3 
Küpeli, 2004 43.74 (21–65) 15 4.9 (3–5) 3/15   
Lee 2014  47.9 ± 11.4 33:21 3.65±1.15 25/54  19.6±8.5 
Liatsikos, 2007  46.33 ± 10.74 6:9 3.00 ± 1.46 9/15  8.8±1.09 
 43.75 ± 11.16 7:9 7.69 ± 1.35 7/16  12.1±1.35 
Lojanapiwat, 2008  46.52 ± 13.63 20:5 6.70 ± 1.66 1/25 23±0
Lv 2014  33.75+-5.24 18:15 7.3+-1.2 20/33 10.65+-2.92 
Miller 1999 36.5    62/75  
Mohseni, 2006  39.3 ± 14.2 (18-61) 24:8 6.6± 3.1 (3.5-10) 20/32  5.9±2.7 
Morua 2009 36.2 ± 12.2  6.4+-1.8 6/15 13.16+-11.5 
Morse 1991 11-88 242:136  228/378  
Ochoa-Gomez 
2011 
38.2 ± 12.4 21:12 5.2 ± 0.39 23/33 23 ± 6.36
Pedro, 2008 42.03 ± 12.85 27 : 8 4.07 ± 1.13 27/35  8.5±6.99 
Pickard 2015 42.8 ± 12.3 294:85 4.5+-1.7 303/379 15.9+-11.3(84)
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Porpiglia, 2000  49 (18-70) 24:24 5.5 ± 1.4 17/48  20 
Porpiglia, 2004  42.7 ± 16 16:12 5.4 ± 1.49 12/28  12 
Porpiglia, 2006  45.2 ± 0.88 (33–50) 12:12 5.5+-0.13 8/24 
Porpiglia, 2009  46 ± 14.6 23:22 6.03+-0.81 22/45  5 
Rahim 2012 33.84+-12.13 31:14 6+-0.53 22/45 19.18+-4.66 
Resim, 2005 33.50 ± 9.7 23:7 7.80 ± 2.2 22/30   
Sameer 2014 33.06 ± 8.76 23:12 6.37 ± 1.85 7/35 12.29+-9.46 
Sayed, 2008 37.1 ± 9.8 (18-58) 35:10 6.4±1.3 (5-10) 23/45  12.5±2.12 
Sfoungaristos  42.40 ± 13.75 7.12±3.57 36/68
Sur 2015 47 ± 15  5.5±1.6 52/117 - 
Sun 2009 37.8+-10.2 24/6 5.7+-1.2 8/30 Median (6 (IQR: 5-
7)) 
Tchey 2011 42.6 3.9±1.8 566/656
Ueno 1977   4.0 ± 1.5 286/520  
Vincendeau 2010 39.0 ± 11.4 52:9 3.2±1.2 43/61  9.6+-9.8 
Wang, 2008 50.9 ± 9.6 23:8 6.5 ± 1.4 17/31  10.1±3 
Wang 2016 51.51 ± 10.03  6.46±1.31 48/62  6.31+-2.13 
Yencilek 2010 33.5 ± 10.1 (22–51) 30:20 6.6±2.7 15/50 11.6+-4.1
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Ye 2017 40 ± 12.3 605:1049 5.7 ± 1.8 1300/1654 10.3  
Yilmaz, 2005 41.60 ± 12.01 19:9 6.07 ± 1.41 15/28  10.5±2.12 
Yuksel 2015 35.23+-11.2 20:15 6.35+-1.57 25/35 12.91+-6.14
Zehri 2010 33.62 25:7 5.49 12/32 12.5+-1.17 
Zhou 2011 34.79 ± 9.63 27:16 6.61 ± 0.74 13/43 9.4 ± 2.48 
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Table 2: Cumulative analysis of results for the included studies 
Parameter Spontaneous Stone Passage Rate/Total 
patients (%) 
 
Overall 4277/6642 (64.4%) 
Location 
- Upper Ureter 
- Mid Ureter 
- Lower Ureter 
 
348/709 (49.1%) 
111/191 (58.1%) 
3442/5056 (68.1%) 
Size 
- <5mm 
- >5mm 
1353/1797 (75.3%) 
1109/1800 (61.6%) 
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Figure 1:  Flowchart  for  article  selection  process  of  the  review 
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Figure 2 : Risk of bias graph: review authors' judgements about each risk of  
bias item presented as percentages across all included studies. 
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